Utah Medical Products (UTMD) Cash from Investing Activities (2010 - 2026)
Utah Medical Products (UTMD) recorded quarterly Cash from Investing Activities of -$130000.0 in Q1 2026, down 19.27% quarter-over-quarter from -$109000.0 in Q4 2025, and up 29.35% on a YoY basis from -$100504.2 in Q1 2025.
Utah Medical Products (UTMD) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Utah Medical Products' Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$130000.0 for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 29.35% year-over-year to -$130000.0; the TTM figure through Mar 2026 stood at -$317000.0 (up 20.15% YoY), while the FY2025 annual figure was -$371000.0, down 78.37% from the prior year.
- Cash from Investing Activities was -$130000.0 for Q1 2026 at Utah Medical Products, down from -$109000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $5000.0 in Q1 2024 to a low of -$321000.0 in Q3 2022.
- Historically, Cash from Investing Activities has averaged -$127411.8 across 5 years, with a median of -$109000.0 in 2025.
- The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities jumped 111.63% in 2024, then plunged 3780.0% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at -$38000.0 in 2022, then sank by 136.84% to -$90000.0 in 2023, then surged by 90.0% to -$9000.0 in 2024, then tumbled by 1111.11% to -$109000.0 in 2025, then fell by 19.27% to -$130000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$130000.0 (Q1 2026), -$109000.0 (Q4 2025), and -$27000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -58.03 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -42.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -77.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -131.58 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -133.00 Mn |
| 10 | Utah Medical Products | 216.87 Mn | 129.46 Mn | 5.28 Mn | -130,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -130,000.00 |
| Mar 31, 2026 | -130,000.00 |
| Dec 31, 2025 | -109,000.00 |
| Dec 31, 2025 | -109,000.00 |
| Sep 30, 2025 | -27,000.00 |
| Sep 30, 2025 | -27,000.00 |
| Jun 30, 2025 | -51,000.00 |
| Jun 30, 2025 | -51,000.00 |
| Mar 31, 2025 | -184,000.00 |
| Mar 31, 2025 | -184,000.00 |
| Dec 31, 2024 | -9,000.00 |
| Dec 31, 2024 | -9,000.00 |
| Sep 30, 2024 | -89,000.00 |
| Sep 30, 2024 | -89,000.00 |
| Jun 30, 2024 | -115,000.00 |
| Jun 30, 2024 | -115,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | -90,000.00 |
| Dec 31, 2023 | -90,000.00 |